Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Impact of a Physical Activity Intervention With Motivational Support From Peers for Prostate Cancer Patients

NCT05739565 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2023-04-25
Last updated
2025-11-24

Condition(s) studied

Prostate Cancer

Investigational drug(s) / intervention(s)

Acti-Pair program

Acti-Pair program: Motivational support by the peer (a patient with the same pathology who meets the WHO recommendations for physical activity), who will provide motivational follow-up * The implementation of a personalized and realistic physical activity project for the patient via the physical activity support systems (sport health centers) * Support from health professionals (GP) via the prescription of physical activity and from adapted physical activity (APA) professionals

Study summary

Despite the recognized benefits of physical activity in tertiary prevention, 60-70% of prostate cancer patients are insufficiently active.

Yet 150 minutes of brisk walking per week (new WHO recommendations) is associated with a 29% reduction in cancer mortality and a 57% reduction in recurrence.

Increasing patients' adherence to regular physical activity appears to be a new challenge for personalized cancer care.

Personalized physical activity programmes (1) at home, (2) supported by health professionals, or (3) by peers have shown the effectiveness of regular physical activity.

However, these interventions last less than 6 months and do not allow for long-term sustainability of physical activity.

This study proposes to combine 3 interventions, which aim to initiate and maintain regular physical activity in prostate cancer patients:

* 1-The realization of a personalized and realistic physical activity project via physical activity support devices (sport health centers)
* 2-Coaching by a peer (a patient with the same disease who has reached the WHO recommendations for physical activity), who will provide motivational follow-up
* 3-Support by health professionals (attending physician) through the prescription of physical activity.

The feasibility of ACTI-PAIR program has been demonstrated, the investigators now wish to evaluate it effectiveness.

Eligibility

Sex
MALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: Patients: * Age ≥ 18 years * Diagnosed with prostate cancer for at least 1 year * PA practice \< 150 minutes per week (considered inactive according to WHO) * Affiliated or entitled to a social security scheme * Having received informed information about the study and having co-signed, with the investigator, a consent to participate in the study Exclusion Criteria: For patients: * Undergoing treatment (except hormone therapy) * Significant comorbidities contraindicating the practice of physical activity: associated cardiac pathologies, respiratory pathologies, disabling joint pathologies * Deprived of liberty or under guardianship

Primary outcome measure(s)

  • Objective measurement of physical activity (in MET-hr/week, Metabolic Equivalent of Task (MET), measures the intensity of physical activity) — Month: 12
    via actimetry (Actigraph GT9x, Pensacola, Florida, USA) 12 months (+/- 1 month) after the patient's inclusion in the Acti-Pair program

Trial sites (25)

FacilityCityRegionStatus
Activité Physique Adaptée - CDOS Savoie Chambéry France Not Yet Recruiting
CH Chambéry Chambéry France Not Yet Recruiting
Activité Physique Adaptée - DAHLIR 63 Clermont-Ferrand France Not Yet Recruiting
CHU Clermont-Ferrand - ONCOLOGIE Clermont-Ferrand France Not Yet Recruiting
CHU Clermont-Ferrand - Urologie Clermont-Ferrand France Not Yet Recruiting
Activité Physique Adaptée - CDOS Isère Grenoble France Not Yet Recruiting
CHU Grenoble - Urologie Grenoble France Not Yet Recruiting
Activité Physique Adaptée - DAHLIR 43 Le Puy-en-Velay France Not Yet Recruiting
CH Le Puy en Velay Le Puy-en-Velay France Not Yet Recruiting
HCL - Hôpital Edouard Herriot Lyon France Not Yet Recruiting
HCL - Hôpital Croix Rousse Lyon France Not Yet Recruiting
Activité Physique Adaptée - DAHLIR 69 Lyon France Not Yet Recruiting
CLB - Oncologie Lyon France Not Yet Recruiting
CLB - Radiothérapie Lyon France Not Yet Recruiting
HCL - CH Lyon Sud Lyon France Not Yet Recruiting
Activité Physique Adaptée - CDOS Ardèche Privas France Not Yet Recruiting
CH Roanne Roanne France Not Yet Recruiting
Activité Physique Adaptée - DAPAP 42 Saint-Etienne France Not Yet Recruiting
CHU Saint-Etienne - Oncologie Saint-Etienne France Recruiting
CHU Saint-Etienne - Radiothérapie Saint-Etienne France Not Yet Recruiting
Hôpital Privé de la Loire Saint-Etienne France Recruiting
Clinique du parc Saint-Priest-en-Jarez France Not Yet Recruiting
Activité Physique Adaptée - CDOS Drôme Valence France Not Yet Recruiting
Hôpitaux Drôme Nord - Valence Valence France Not Yet Recruiting
Radiologie Drôme-Ardèche - Valence Valence France Not Yet Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05739565 on ClinicalTrials.gov ↗ ← All trials in France